Novel OAB treatment vibegron does not adversely affect blood pressure

In this video, Michael A. Weber, MD, discusses the background and findings of the study, “Effects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind study,” presented at the 2021 American Urological Association Annual Meeting. Weber is a professor of medicine and associate dean of research at Downstate College of Medicine, State University of New York, Brooklyn, New York.